Rituximab use in adult primary glomerulopathy: where is the evidence?

Rituximab use in adult primary glomerulopathy: where is the evidence?

Samir G Mallat,1 Houssam S Itani,2 Rana M Abou-Mrad,3 Rima Abou Arkoub,4 Bassem Y Tanios1 1Division of Nephrology, Department of Internal Medicine, American University of Beirut Medical Center, 2Division of Nephrology, Department of Internal Medicine, Makassed General Hospital, Beirut, Lebanon; 3Sp...

Full description

Bibliographic Details
Main Authors: Mallat SG, Itani HS, Abou-Mrad RM, Abou Arkoub R, Tanios BY
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Rituximab therapy
Primary glomerulopathy
Adult Glomerunephritis
membranous nephropathy
minimal change disease
focal segmental glomerulosclerosis
Online Access:https://www.dovepress.com/rituximab-use-in-adult-primary-glomerulopathy-where-is-the-evidence-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/rituximab-use-in-adult-primary-glomerulopathy-where-is-the-evidence-peer-reviewed-article-TCRM

Similar Items